_live-virtual-symposium-a-deeper-dive-into-nash-diagnosis-and-treatment-an-augmented-reality-experience.jpg "Live Virtual Symposium: A Deeper Dive into NASH Diagnosis and Treatment: An Augmented Reality Experience from fibrosis of the liver stage 1 Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 81 min 39 sec
✓ Published: 22-Apr-2020
✓ Published: 22-Apr-2020
Description:
Obesity and diabetes are on the rise, leading to an increased prevalence of non-alcoholic fatty liver disease (NAFLD), which in some cases may progress to non-alcoholic steatohepatitis (NASH). NAFLD effects approximately 30% of the U.S. population, with NASH effecting about 5%. NASH comes with a significant risk of progression to advanced liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Disease models project that the number of individuals with end-stage liver disease will double -
Obesity and diabetes are on the rise, leading to an increased prevalence of non-alcoholic fatty liver disease (NAFLD), which in some cases may progress to non-alcoholic steatohepatitis (NASH). NAFLD effects approximately 30% of the U.S. population, with NASH effecting about 5%. NASH comes with a significant risk of progression to advanced liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Disease models project that the number of individuals with end-stage liver disease will double -
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_progression-of-liver-disease-webcast-series-stages-of-liver-disease.webp "American Liver Foundation")
_liver-health-amp-diabetes.webp "Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It is highly prevalent and is associated with significant adverse outcomes and is closely associated with type 2 diabetes and obesity, and both of these conditions drive progressive disease toward the more advanced stages. The ability to make an accurate assessment of disease stage can also be challenging. Liver")
_liver-fibrosis-stages-and-symptoms.webp "HEALTHY FIT")
_how-dangerous-is-liver-fibrosis.webp "Wander Woman")
_cirrhosis-causes-symptoms-diagnosis-treatment-pathology.webp "Osmosis from Elsevier")
_how-long-can-you-live-after-being-diagnosed-with-cirrhosis-of-the-liver.webp "Yashoda Hospitals - Hyderabad")
_hepatic-cirrhosis-124-2-minute-gastroenterology-124-medicine-video-124-v-learning-124-sqadia-com.webp "This short clip of Gastroenterology explains the pathophysiology of cirrhosis of the liver. Hepatic cirrhosis is defined histologically as a diffuse hepatic process characterized by fibrosis and conversion of normal liver architecture into structurally abnormal nodules. It may take weeks to years to occur.nn----------------------------------------nGastroenterology Medicine Lectures Collection -nhttps://www.sqadia.com/categories/medicine-gastroenterologyn----------------------------------------")
⏲ 1 min 35 sec ✓ 17-Aug-2020
_resmetirom-for-nash-with-liver-fibrosis-124-nejm.webp "NEJM Group")
_progression-of-liver-disease-webcast-series-stages-of-liver-disease.jpg)
_liver-health-amp-diabetes.jpg)
_liver-fibrosis-stages-and-symptoms.jpg)
_how-dangerous-is-liver-fibrosis.jpg)
_cirrhosis-causes-symptoms-diagnosis-treatment-pathology.jpg)
_how-long-can-you-live-after-being-diagnosed-with-cirrhosis-of-the-liver.jpg)
_hepatic-cirrhosis-124-2-minute-gastroenterology-124-medicine-video-124-v-learning-124-sqadia-com.jpg)
_resmetirom-for-nash-with-liver-fibrosis-124-nejm.jpg)
![[+]](/images/menu.gif){kind=small}